About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Mammogram Mail- and Phone-based Interventions | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05853848

Mammogram Mail- and Phone-based Interventions

The project aims to evaluate four different versions and modalities of interventions encouraging mammogram screening among all eligible women due or overdue for screening. The evaluation will compare ...

Lead sponsor: Geisinger Clinic•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Geisinger Clinic

Age

51 - 74 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Female Geisinger Health Plan members between ages 52 and 74 as of December 31, 2023
•Overdue for annual mammogram
•Continuously enrolled with the Geisinger Health Plan as of October 1, 2021
•Can be contacted via both phone and mail

Exclusion Criteria

•Geisinger Health Plan members on a do-not-contact list
•Had a mammogram as of October 1, 2021
•In hospice, using hospice services, or receiving palliative care as of January 1, 2023
•Medicare members 66 years of age or above at time of outreach, who are institutionalized or have both frailty and advanced illness
•Had a bilateral mastectomy at any time

Related studies

RECRUITINGPhase 1

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

NCT06347068 · Breast Cancer, Relapse, and more

RECRUITINGPhase 3

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

NCT06500481 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more

A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship

NCT07655934 · Breast Cancer

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

NCT07436078 · Female Breast Cancer, Prostate Cancer, and more

RECRUITINGPhase 1/2

Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

NCT07288359 · Advanced HR+/HER2- Breast Cancer, Advanced CCNE1-amplified Solid Tumors, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 10, 2024Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment14,386

Start dateMay 2023

Last updatedOct 10, 2024

Condition

Locations shown

Geisinger

Danville, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 10, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions